It was reported that, after a thr surgery, the patient had a femur fracture.A revision surgery was performed on (b)(6) 2023 in order to explant an oxinium fem hd 12/14 36 mm -3, a polarstem stem std ti/ha 3 non-cem and a r3 0 deg xlpe acet lnr 36mm x 52mm, and replace them with or3o and a redapt 240mm stem.The patient current health status is unknown.
|
H3, h6: the devices were not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that, this case reports, after a thr surgery (date unspecified) the patient reportedly experienced a femur fracture and subsequent revision with extraction of the head, liner, and stem.The implants were ¿replaced with or30 and a redapt 240mm stem.¿ as of the date of this medical investigation, the requested clinical documentation has not been provided; therefore, there were no clinical factors found which would have contributed to the event.The patient impact beyond the reported events including the revision cannot be determined.The patient¿s current health status is unknown.Therefore, no further clinical/medical assessment can be rendered.A review of the production orders did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.For oxinium fem hd 12/14 36 mm -3 and r3 0 deg xlpe acet lnr 36mm x 52mm, a review of complaint history for the part number over the past 12 months and for the batch number based on historical data of the device did not reveal similar events for the listed device.For polarstem stem std ti/ha 3 non-cem, a review of complaint history revealed similar events for the listed device over the previous 12 months, but no similar events for the batch based on the historical data, this failure mode will be monitored for future complaints for any necessary corrective actions.A review of the instructions for use documents for total hip systems revealed in warnings and precautions that congenital deformity, improper implant selection, improper broaching or reaming, osteoporosis, bone defects due to misdirected reaming, trauma, strenuous activity, improper implant alignment or placement, patient non-compliance, etc.Can increase risk of femoral or pelvic fractures.A review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this products and event.At this time, we have no reason to suspect that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include patient bone quality, post-operative patient condition and/or surgical technique.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
|